Sumipao, Narcelyn .
HRN: 21-29-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
CEFUROXIME 500MG (TAB)
05/03/2022
05/10/2022
ORAL
500mg
Q12H
UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes